Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients

At the start of the COVID-19 pandemic, the BNT162b2 (BioNTech-Pfizer) and mRNA-1273 (Moderna) mRNA vaccines were expediently designed and mass produced. Both vaccines produce the full-length SARS-CoV-2 spike protein for gain of immunity and have greatly reduced mortality and morbidity from SARS-CoV-...

Descripción completa

Detalles Bibliográficos
Autores principales: Krauson, Aram J., Casimero, Faye Victoria C., Siddiquee, Zakir, Stone, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533894/
https://www.ncbi.nlm.nih.gov/pubmed/37758751
http://dx.doi.org/10.1038/s41541-023-00742-7

Ejemplares similares

Ejemplares similares